ASMB
Assembly Biosciences Inc
NASDAQ: ASMB · HEALTHCARE · BIOTECHNOLOGY
$26.95
+2.35% today
Updated 2026-04-30
Market cap
$442.93M
P/E ratio
—
P/S ratio
6.13x
EPS (TTM)
$-0.55
Dividend yield
—
52W range
$11 – $40
Volume
0.1M
WallStSmart proprietary scores
44
out of 100
Grade: D
Sell
Investment rating
6.3
Growth
B6.5
Quality
B4.0
Profitability
C6.7
Valuation
B3/9
Piotroski F-Score
Weak
-8.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$48.75
+80.89%
12-Month target
—
—
Intrinsic (DCF)
$59.74
Margin of safety
+54.20%
0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $14.21M — positive
+ Revenue growth 477.30% QoQ
+ 54.20% below intrinsic value
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -8.52 — distress zone
- Thin margins at -8.47%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $7.16M | $28.52M | $72.30M | $72.30M |
| Net income | $-92.07M | $-61.23M | $-40.18M | $-6.12M | $22.09M |
| EPS | — | — | — | — | $-0.55 |
| Free cash flow | $-84.56M | $22.49M | $-51.15M | $-41.16M | $14.21M |
| Profit margin | — | -854.78% | -140.87% | -8.47% | -8.47% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-08-08 | GILEAD, SCIENCES, INC. | Buy | 2,295,920 | — |
| 2025-08-08 | GILEAD, SCIENCES, INC. | Buy | 1,147,960 | — |
| 2025-08-08 | GILEAD, SCIENCES, INC. | Buy | 1,147,960 | — |
Peer comparison
Smart narrative
Assembly Biosciences Inc trades at $26.95. Our Smart Value Score of 44/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -8.52, it sits in the distress. TTM revenue stands at $72.30M. with profit margins at -8.47%. Our DCF model estimates intrinsic value at $59.74.
Frequently asked questions
What is Assembly Biosciences Inc's stock price?
Assembly Biosciences Inc (ASMB) trades at $26.95.
Is Assembly Biosciences Inc overvalued?
Smart Value Score 44/100 (Grade D, Sell). DCF value $59.74.
What is the price target of Assembly Biosciences Inc (ASMB)?
The analyst target price is $48.75, representing +80.9% upside from the current price of $26.95.
What is the intrinsic value of Assembly Biosciences Inc (ASMB)?
Based on our DCF model, intrinsic value is $59.74, a +54.2% margin of safety versus $26.95.
What is Assembly Biosciences Inc's revenue?
TTM revenue is $72.30M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-8.52 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.13x
ROE-5.10%
Beta1.16
50D MA$28.57
200D MA$27.93
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week+2.12%
1 month-0.65%
3 months+0.00%
YTD-19.08%
1 year—
3 years—
5 years—